1,069 research outputs found

    Divide-and-Conquer Distributed Learning: Privacy-Preserving Offloading of Neural Network Computations

    Get PDF
    Machine learning has become a highly utilized technology to perform decision making on high dimensional data. As dataset sizes have become increasingly large so too have the neural networks to learn the complex patterns hidden within. This expansion has continued to the degree that it may be infeasible to train a model from a singular device due to computational or memory limitations of underlying hardware. Purpose built computing clusters for training large models are commonplace while access to networks of heterogeneous devices is still typically more accessible. In addition, with the rise of 5G networks, computation at the edge becoming more commonplace, and inspired by the successes of the folding@home project utilizing crowdsourced computation, we consider the scenario of the crowdsourcing the computation required for training of a neural network particularly appealing. Distributed learning promises to bridge the widening gap between singular device performance and large-scale model computational requirements, but unfortunately, current distributed learning techniques do not maintain privacy of both the model and input with- out an accuracy or computational tradeoff. In response, we present Divide and Conquer Learning (DCL), an innovative approach that enables quantifiable privacy guarantees while offloading the computational burden of training to a network of devices. A user can divide the training computation of its neural network into neuron-sized computation tasks and dis- tribute them to devices based on their available resources. The results will be returned to the user and aggregated in an iterative process to obtain the final neural network model. To protect the privacy of the user’s data and model, shuffling is done to both the data and the neural network model before the computation task is distributed to devices. Our strict adherence to the order of operations allows a user to verify the correctness of performed computations through assigning a task to multiple devices and cross-validating their results. This can protect against network churns and detect faulty or misbehaving devices

    Pathways to Drug Liberalization: Racial Justice, Public Health, and Human Rights

    Get PDF
    In our recent article, together with more than 60 of our colleagues, we outlined a proposal for drug policy reform consisting of four specific yet interrelated strategies: (1) de jure decriminalization of all psychoactive substances currently deemed illicit for personal use or possession (so-called “recreational” drugs), accompanied by harm reduction policies and initiatives akin to the Portugal model; (2) expunging criminal convictions for nonviolent offenses pertaining to the use or possession of small quantities of such drugs (and releasing those serving time for these offenses), while delivering retroactive ameliorative relief; (3) the ultimate legalization and careful regulation of currently illicit drugs; and (4) the delivery of a new “Marshall Plan” focused on community-building initiatives, expanded harm reduction programs, and social and health care support efforts (Earp et al. 2021). We were gratified to see so many thoughtful commentaries on our proposal, and we respond to them in part in this reply

    Synthesis and characterisation of cationic quaternary ammonium-modified polyvinyl alcohol hydrogel beads as a drug delivery embolisation system

    Get PDF
    To extend the platform of clinically utilised chemoembolic agents based on ion-exchange systems to support the delivery of anionic drugs, a series of PVA-based beads was produced with different levels of (3-acrylamidopropyl)trimethylammonium chloride (APTA) in their formulation. The beads were characterised to confirm composition and the effect of formulation variation on physical properties was assessed. Suspension polymerisation was shown to successfully produce uniformly spherical copolymer beads with APTA content up to 60 wt%. Equilibrium water content and resistance to compression both increased with increasing APTA content in the formulation. Confocal laser scanning microscopy was used with model drugs to demonstrate that by increasing APTA content, compounds between the molecular weight range 70–250 kDa could permeate the microsphere structures. Interaction with anionic drugs was modelled using multivalent dyes. Dyes with multi-binding sites had increased interaction with the polymer, slowing the release and also demonstrating a reduced rate of elution from beads with higher charge density. The model drug release studies demonstrate that these systems can be engineered for different potential anionic drugs for local therapeutic delivery in the clinic

    Multi-locus sequence typing of Escherichia coli isolates with acquired ampC genes and ampC promoter mutations

    Get PDF
    © 2016 Elsevier Inc. Multi-locus sequence typing was used to reveal a high degree of diversity amongst the E. coli isolates with AmpC plasmid genes, and a high prevalence of the −32 mutation present

    Papers in New Guinea Linguistics No. 26

    Get PDF

    Constraining slow-roll inflation with WMAP and 2dF

    Get PDF
    We constrain slow-roll inflationary models using the recent WMAP data combined with data from the VSA, CBI, ACBAR and 2dF experiments. We find the slow-roll parameters to be 0<Ï”1<0.0320 < \epsilon_1 < 0.032 and Ï”2+5.0Ï”1=0.036±0.025\epsilon_2 + 5.0 \epsilon_1 = 0.036 \pm 0.025. For inflation models V∝ϕαV \propto \phi^{\alpha} we find that α<3.9,4.3\alpha< 3.9, 4.3 at the 2σ\sigma and 3σ3\sigma levels, indicating that the λϕ4\lambda\phi^4 model is under very strong pressure from observations. We define a convergence criterion to judge the necessity of introducing further power spectrum parameters such as the spectral index and running of the spectral index. This criterion is typically violated by models with large negative running that fit the data, indicating that the running cannot be reliably measured with present data.Comment: 8 pages RevTeX4 file with six figures incorporate

    Chromosomal ampC mutations in cefpodoxime-resistant ESBL-negative uropathogenic escherichia coli

    Get PDF
    AmpC beta-lactamase is an enzyme commonly produced by Escherichia coli that causes resistance to cephalosporins and penicillins. Enzyme production is controlled by the strength of the promoter encoded by the chromosomal ampC gene, with the level of production affected by the presence of certain mutations in this region. This study sets out to determine the prevalence of ampC promoter mutations present in a group of uropathogenic E. coli strains. A total of 50 clinical strains of E. coli were collected from urine samples between June 2011 and November 2011. Strains were investigated for the presence of mutations in the chromosomal ampC promoter region by amplification and sequencing of a 271 bp product. The presence of ampC-carrying plasmids derived from other species was also determined, to exclude these from further analysis. ampC-carrying plasmids were found in 10 of the 50 strains, all of which were of the CIT-type. Analysis of the chromosomal ampC promoter region in the 40 remaining strains showed mutations at 16 different positions, with 18 different genotype patterns detected overall. The most common ampC chromosomal mutation, present in 25 of 40 strains, was a T→A transition at position -32. This mutation has been shown by others to increase enzyme production by up to 46-fold. Altogether, three separate mutations (-32, -42 and -13ins) were present in 90% of the 40 non-plasmid strains, indicating a strong association with the resistance observed. It appears, therefore, that the majority of AmpC-mediated resistance in E. coli can be accounted for by just three point mutations in the chromosome
    • 

    corecore